Table 1 |
|||
|
Model data. Costs in SEK 2004 (95% confidence intervals in parenthesis). |
|||
| Type of data |
Group |
Estimate |
Source |
|
|
|||
| Annual risk of hip fracture |
men 65–79 y |
0.0049 |
Effect evaluation |
| men 80+ y |
0.0175 |
||
| women 65–79 y |
0.0053 |
||
| women 80+ y |
0.0261 |
||
| Death risks after hip fracture |
1st year after hip fracture: 2nd and following years after fracture: age- and gender-specific |
pers.com. F. Borgström, Stockholm Health Economics, 2006-11-17 |
|
| Death risks |
age- and gender-specific |
National Death Register |
|
| Health care costs |
initial cost |
110,364 (105,123 – 115,221) |
Stockholm County Council healthcare data base |
| annual cost |
12,590 (11,141 – 14,243) |
||
| Community care |
annual cost |
38,200 (26,304 – 55,711) |
[21] |
| Pharmaceuticals |
annual cost |
1,552 (1,360 – 1,753) |
[21] |
| Informal care |
annual cost |
3,223 (1,954 – 5,524) |
[21] |
| QoL reduction from hip fracture |
annual |
0.17 |
[21] |
| Average QoL |
men 65–69 y |
0.78 |
[22] |
| men 70–79 y |
0.76 |
||
| men 80+ y |
0.68 |
||
| women 65–69 y |
0.75 |
||
| women 70–79 y |
0.66 |
||
| women 80+ y |
0.57 |
||
|
|
|||
|
Johansson et al. Cost Effectiveness and Resource Allocation 2008 6:11 doi:10.1186/1478-7547-6-11 |
|||
